Self-assembling process in tissue engineering of articular cartilage

关节软骨组织工程中的自组装过程

基本信息

  • 批准号:
    9755352
  • 负责人:
  • 金额:
    $ 40.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-01 至 2022-05-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The self-assembling process in articular cartilage is emerging as a potentially robust approach for engineering large and small cartilage constructs. The objective of this proposal is to evaluate self-assembled articular cartilage in resurfacing the patella by quantifying the biologic response (i.e., host response to the construct), dose response (i.e., identifying the minimum number of necessary cells), and durability (i.e., stability, integriy, and maturation over a year), as defined by the FDA. Statistical optimization to improve the functionality of self- assembled cartilage constructs has yielded a powerful combination of externally applied stimuli that result in constructs with biomechanical and biochemical properties on par with those of native cartilage. Among a multitude of helpful stimuli, three have emerged as quite potent: hydrostatic pressure (10MPa at 0Hz during days 10-14), TGF-ß1 (30 ng/ml for 2 wks), and chondroitinase ABC (applied at 2 wks), applied in combination. Mechanisms linking these stimuli to the engineered tissues' biomechanical properties have also been elucidated to explain their synergisms and to consolidate them into simple culture protocols. A functionality index (FI) allowing the establishment of quantitative success criteria and validated for the comparison of constructs to native tissue showed that construct properties have attained FI values approaching 1, the value of native tissue. Based on these promising results and additional in vivo murine, leporine, and ovine data, this proposal will investigate the global hypothesis that constructs will show durability without an adverse host response via three aims: The objective of Aim 1 is to use a short-term (12wks), leporine patella resurfacing model to examine the hypotheses that: 1) not only will constructs retain stability and integrity in vivo, thir FI values will be improved by implantation, and 2) neither the allogeneic cells nor the culture products will elicit adverse host responses (local/systemic). Aim 2 employs the murine model to validate that implant scale-up would not alter neocartilage biomechanical properties. Aim 2 will also address certain challenges that are common across diverse cartilage regeneration strategies, namely initial fixation, subsequent integration, and durability against wear; these issues will be tackled using a chondroconductive glue, exogenous lysyl oxidase, and the chondrotuning method that yields robust and lubricious implants. Finally, Aim 3 will test the hypothesis that durable healing can be achieved for up to 12 months in an ovine model. This aim will also identify a minimum cell number that can be employed to achieve effective healing at 1 year. By following FDA's guidance document ("Preparation of IDEs and INDs for products intended to repair or replace knee cartilage"), and if the proposed study's hypotheses are proven, the results will provide exciting validation of the clinical translatability of self-assembed articular cartilage constructs.


项目成果

期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Engineering large, anatomically shaped osteochondral constructs with robust interfacial shear properties.
  • DOI:
    10.1038/s41536-021-00152-0
  • 发表时间:
    2021-08-06
  • 期刊:
  • 影响因子:
    7.2
  • 作者:
    Brown WE;Huang BJ;Hu JC;Athanasiou KA
  • 通讯作者:
    Athanasiou KA
Articular cartilage tissue engineering: the role of signaling molecules.
Multimodal fluorescence lifetime imaging and optical coherence tomography for longitudinal monitoring of tissue-engineered cartilage maturation in a preclinical implantation model.
  • DOI:
    10.1117/1.jbo.28.2.026003
  • 发表时间:
    2023-02
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Zhou, Xiangnan;Haudenschild, Anne K.;Li, Cai;Marcu, Laura
  • 通讯作者:
    Marcu, Laura
Cell-based tissue engineering strategies used in the clinical repair of articular cartilage.
  • DOI:
    10.1016/j.biomaterials.2016.04.018
  • 发表时间:
    2016-08
  • 期刊:
  • 影响因子:
    14
  • 作者:
    Huang BJ;Hu JC;Athanasiou KA
  • 通讯作者:
    Athanasiou KA
Shear stress induced by fluid flow produces improvements in tissue-engineered cartilage.
  • DOI:
    10.1088/1758-5090/aba412
  • 发表时间:
    2020-08-10
  • 期刊:
  • 影响因子:
    9
  • 作者:
    Salinas EY;Aryaei A;Paschos N;Berson E;Kwon H;Hu JC;Athanasiou KA
  • 通讯作者:
    Athanasiou KA
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kyriacos A Athanasiou其他文献

Characterization of the temporomandibular joint disc complex in the Yucatan minipig.
尤卡坦小型猪颞下颌关节盘复合体的特征。
  • DOI:
    10.1089/ten.tea.2023.0011
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    R. Donahue;Eston G Kallins;Jerry C. Hu;Kyriacos A Athanasiou
  • 通讯作者:
    Kyriacos A Athanasiou
Adult dermal stem cells for scaffold-free cartilage tissue engineering - exploration of strategies.
用于无支架软骨组织工程的成体真皮干细胞——策略探索。
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    N. Vapniarsky;H. Kwon;N. Paschos;A. Haudenschild;W. E. Brown;Gayson DuRaine;Jerry C. Hu;Kyriacos A Athanasiou
  • 通讯作者:
    Kyriacos A Athanasiou
Mechanical Evaluation of Commercially Available Fibrin Sealants for Cartilage Repair.
用于软骨修复的市售纤维蛋白密封剂的机械评估。
  • DOI:
    10.1177/19476035231163273
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    Arya Amirhekmat;W. E. Brown;E. Y. Salinas;Jerry C. Hu;Kyriacos A Athanasiou;Dean Wang
  • 通讯作者:
    Dean Wang

Kyriacos A Athanasiou的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kyriacos A Athanasiou', 18)}}的其他基金

Liquid cartilage for arthroscopy
关节镜用液体软骨
  • 批准号:
    10649312
  • 财政年份:
    2023
  • 资助金额:
    $ 40.03万
  • 项目类别:
Laser Scanning Vibrometer
激光扫描测振仪
  • 批准号:
    10415806
  • 财政年份:
    2022
  • 资助金额:
    $ 40.03万
  • 项目类别:
Toward tissue engineering of facet cartilage
面向小面软骨的组织工程
  • 批准号:
    10398793
  • 财政年份:
    2021
  • 资助金额:
    $ 40.03万
  • 项目类别:
Toward tissue engineering of facet cartilage
面向小面软骨的组织工程
  • 批准号:
    10571696
  • 财政年份:
    2021
  • 资助金额:
    $ 40.03万
  • 项目类别:
TMJ Disc Regeneration
颞下颌关节盘再生
  • 批准号:
    10238212
  • 财政年份:
    2020
  • 资助金额:
    $ 40.03万
  • 项目类别:
TMJ Disc Regeneration
颞下颌关节盘再生
  • 批准号:
    9930175
  • 财政年份:
    2019
  • 资助金额:
    $ 40.03万
  • 项目类别:
Engineering biomimetic knee menisci with zonal and anisotropic variations
具有分区和各向异性变化的仿生膝关节半月板工程
  • 批准号:
    10199936
  • 财政年份:
    2017
  • 资助金额:
    $ 40.03万
  • 项目类别:
Engineering biomimetic knee menisci with zonal and anisotropic variations
具有分区和各向异性变化的仿生膝关节半月板工程
  • 批准号:
    10425800
  • 财政年份:
    2017
  • 资助金额:
    $ 40.03万
  • 项目类别:
Engineering biomimetic knee menisci with zonal and anisotropic variations
具有分区和各向异性变化的仿生膝关节半月板工程
  • 批准号:
    9755363
  • 财政年份:
    2017
  • 资助金额:
    $ 40.03万
  • 项目类别:
Self-assembling process in tissue engineering of articular cartilage
关节软骨组织工程中的自组装过程
  • 批准号:
    9269147
  • 财政年份:
    2015
  • 资助金额:
    $ 40.03万
  • 项目类别:

相似海外基金

HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to the heart (HEAL)
HLA-纯合 iPSC-心肌细胞 用于心脏同种异体细胞治疗 (HEAL) 的聚集体制造技术
  • 批准号:
    10039902
  • 财政年份:
    2022
  • 资助金额:
    $ 40.03万
  • 项目类别:
    EU-Funded
Evaluation of the efficacy of LAT1 inhibitor to tumor stroma and immunity in an allogenic mouse model of colon cancer having abundant stroma.
在具有丰富基质的同种异体结肠癌小鼠模型中评估 LAT1 抑制剂对肿瘤基质和免疫的功效。
  • 批准号:
    21K15925
  • 财政年份:
    2021
  • 资助金额:
    $ 40.03万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanism of kidney injury associated with graft-versus-host disease after allogenic stem cell transplantation
同种异体干细胞移植后移植物抗宿主病相关肾损伤的机制
  • 批准号:
    21K08410
  • 财政年份:
    2021
  • 资助金额:
    $ 40.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clarification of the origin and maintenance mechanisms of junctional epithelium and identification of its stem cells using allogenic tooth germ transplantation
阐明交界上皮的起源和维持机制并利用同种异体牙胚移植鉴定其干细胞
  • 批准号:
    20K21672
  • 财政年份:
    2020
  • 资助金额:
    $ 40.03万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
The study about the allogenic MSCs transplantation to the cardiac disease models.
同种异体间充质干细胞移植至心脏病模型的研究。
  • 批准号:
    18K16395
  • 财政年份:
    2018
  • 资助金额:
    $ 40.03万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Artificial nerves containing allogenic basal lamellae scaffold and bone marrow derived stem cells
含有同种异体基底板层支架和骨髓干细胞的人工神经
  • 批准号:
    17K10951
  • 财政年份:
    2017
  • 资助金额:
    $ 40.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of HSP90-alpha in preserving immunoprivilege of allogenic mesenchymal stem cells in the ischemic heart
HSP90-α 在保护缺血心脏同种异体间充质干细胞免疫特权中的作用
  • 批准号:
    370541
  • 财政年份:
    2017
  • 资助金额:
    $ 40.03万
  • 项目类别:
    Operating Grants
Attempt to Prefabricate Vascularized Allogenic Bone in Recipient -Use of Cultured Bone Marrow Cells-
尝试在受者体内预制血管化的同种异体骨 - 使用培养的骨髓细胞 -
  • 批准号:
    16K10863
  • 财政年份:
    2016
  • 资助金额:
    $ 40.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Allogenic micobiota-reconstitution (AMR) for the treatment of patients with diarhea-predominant irritable bowel syndrome (IBS-D) - the AMIRA trial
同种异体微生物群重建 (AMR) 用于治疗腹泻型肠易激综合征 (IBS-D) 患者 - AMIRA 试验
  • 批准号:
    276706135
  • 财政年份:
    2015
  • 资助金额:
    $ 40.03万
  • 项目类别:
    Clinical Trials
Induction of thyme epithelial cells from iPS cells and application to allogenic transplantation
iPS细胞诱导百里香上皮细胞及其在同种异体移植中的应用
  • 批准号:
    15H04915
  • 财政年份:
    2015
  • 资助金额:
    $ 40.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了